Search
JD Health Shares Surge More Than 5% Post-Earnings Announcement, Q3 Operating Profit Surges 125.3% Year-on-Year
1 week ago /
Read about 0 minute
Author：小编
Following the earnings announcement, JD Health's share price jumped by over 5%, climbing 4.11% as of the time of reporting, and was trading at HK$67.15 with a trading volume of HK$281 million. In the third quarter of 2025, the company reported revenue of RMB 17.12 billion, marking a 28.7% increase from the same period the previous year. Moreover, its operating profit soared to RMB 1.243 billion, representing a remarkable 125.3% year-on-year surge. During this quarter, JD Health entered into strategic cooperation agreements with well-known pharmaceutical firms including Eli Lilly, Innovent Biologics, Eisai China, and Bayer China. Through these partnerships, it exclusively launched a range of new drugs and health products on its platform.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
